Has Cooper Wriston, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,588 in general payments to Cooper Wriston, MD across 46 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cooper Wriston, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cooper Wriston, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cooper Wriston, MD

Dermatology · Burlington, VTNPI 1134356728

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,111 and has fallen 98.5% since, to $16 in 2024. Among dermatology clinicians in VT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,588in general payments, 2019–2025

Across 46 payments — averaging $34.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$358
Regeneron Healthcare Solutions, Inc.$308
Dermavant Sciences, Inc.$130
AbbVie$125
UCB, Inc.$124
Arcutis Biotherapeutics, Inc.$119
plus $424 from 11 others

What the payments were for

Food & beverage$1,588100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	9	$358
Regeneron Healthcare Solutions, Inc.	8	$308
Dermavant Sciences, Inc.	1	$130
AbbVie(2 entities)	6	$125
UCB, Inc.	4	$124
Arcutis Biotherapeutics, Inc.	1	$119
Sun Pharmaceutical Industries Inc.	3	$92
Johnson & Johnson	2	$68
Biofrontera Inc.	2	$42
Pfizer	2	$37
Bristol Myers Squibb	2	$34
Strata Skin Sciences, Inc.	1	$34
Sanofi	1	$30
Amgen	1	$28
Boehringer Ingelheim	1	$25
Incyte Corporation	1	$22
Promius Pharma LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VTAMA$130
DUPIXENT$125
TALTZ$120
OLUMIANT$111

How this compares

$1,588 in reported general payments places this provider in the 95th percentile of 27 dermatology providers in Vermont.

See all dermatology providers in Vermont →

Medicare billing

Part B allowed, 2024

$82,255

Medicare patients

211

Services billed

1,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluocinonide	35	$1,497
Clobetasol Propionate	40	$1,449
Triamcinolone Acetonide	71	$917
Minocycline Hcl	32	$859
Hydrocortisone	34	$567
Metronidazole	14	$546
Fluticasone Propionate	20	$479
Mometasone Furoate	20	$385
Ketoconazole	26	$325
Doxycycline Monohydrate	11	$125

Paid to pharmacies, not to this prescriber.

Other dermatology in Burlington

Julia BarkerBurlington$115
Alyssa FischerBurlington$15
Santana VandykeBurlington$0
Todd HolmesBurlington$0
Mary MaloneyBurlington$0
Joseph PiersonBurlington$0
Christine WeinbergerBurlington$0
Ankit GorBurlington$0
Melanie BuiBurlington$0
Katelyn SheaBurlington$0

See the full list for Vermont →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →